CTN-0144: Better Together: Integrating MOUD in African American Community Settings (NIH HEAL Initiative)
Richard Schottenfeld, MD
Co-Principal Investigator
Howard University
Department of Psychiatry & Behavioral Health
richard.schottenfeld@Howard.edu
Niranjan Karnik, MD, PhD
Co-Principal Investigator
University of Illinois Chicago
Department of Psychiatry
nkarnik@uic.edu
José Szapocznik, PhD
Co-Principal Investigator
University of Miami School of Medicine
Center for Family Studies
jszapocz@med.miami.edu
Black/African American persons in urban communities are experiencing the fastest increases and high rates of opioid overdose deaths and high disparities in engagement and retention in MOUD treatment. This multisite hybrid implementation-effectiveness clinical trial aims to evaluate the integration of MOUD with buprenorphine in trusted, non-medical community settings (including faith-based or secular community centers, churches, mosques, or family support centers) with Peer Recovery Specialists and recovery guide counseling to improve engagement and retention in MOUD treatment of Black persons with OUD. In addition, this study will evaluate implementation barriers and facilitators.
Funded by the NIH HEAL InitiativeSM.
Related Resources
Node Involvement
Lead Node(s):